PALO ALTO, Calif., Oct. 24, 2019 /PRNewswire/ -- Varian (NYSE: VAR)
today announced it was selected by The Ohio
State University to equip a new multi-room proton therapy
center in central Ohio with the
ProBeam 360° system. This new proton facility is a collaboration
between The Ohio State University
Comprehensive Cancer Center- Arthur G. James Cancer Hospital and
Richard J. Solove Research Institute (OSUCCC – James) and
Nationwide Children's Hospital. The facility will treat both adult
and pediatric cancer patients and is scheduled for completion in
early 2023. In addition to the ProBeam® 360°
system, Varian will also install its ARIA® oncology
information management system and Eclipse™ treatment planning
software.
Proton therapy is an advanced form of cancer care. Protons are
accelerated to about two-thirds the speed of light, or more than
100,000 miles per second, to destroy cancer cells, while minimizing
exposure to nearby healthy tissues.
The ProBeam 360° system features the most powerful particle
accelerator available today to treat cancer, a 360-degree gantry
for clinical efficiency, and iterative cone-beam CT imaging and
high-definition pencil-beam scanning for exceptional precision.
"We are committed to creating a state-of-the-art radiation
oncology treatment center and expanding our treatment options to
include proton therapy is a perfect fit with our goals," said
Arnab Chakravarti, MD, chair
of radiation oncology at the OSUCCC – James. "This system will
enable us to deliver the most advanced treatments and provide a
technical platform for the development of potential new treatments
such as FLASH therapy*."
"To realize a world without fear of cancer, it will require both
increased access to advanced cancer care such as proton therapy and
the continuing development of new treatment capabilities," said
Kolleen Kennedy, president, Proton
Solutions and chief growth officer, Varian. "Ohio State has an exceptional clinical and research
radiation oncology enterprise. We look forward to building upon our
strong multi-year strategic research relationship with the
potential to accelerate advanced capabilities such as FLASH
therapy."
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
*FLASH therapy is under preclinical research. It is not
available for clinical use and there is no guarantee of future
commercialization.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-probeam-360-system-selected-by-the-ohio-state-university-for-new-proton-therapy-center-300944519.html
SOURCE Varian